.
  • NIFTY 25,880.45 -80.10 (-0.31%)
  • SENSEX 84,817.28 -285.41 (-0.34%)
 
BSE
NSE

Tuesday, December 09, 2025 , BSE Sensex : 84,817.28 84,817.28(-0.34%) , Adani Ports : 1,492.40 1,492.40(0.85%) , Asian Paints : 2,800.50 2,800.50(-4.28%) , Axis Bank : 1,279.70 1,279.70(0.48%) , Bajaj Finance : 1,020.00 1,020.00(-0.61%) , Bajaj Finserv : 2,071.85 2,071.85(0.63%) , Bharat Electron : 390.60 390.60(1.06%) , Bharti Airtel : 2,086.20 2,086.20(0.01%) , Eternal Ltd : 289.15 289.15(1.37%) , HCL Technologies : 1,670.00 1,670.00(-1.07%) , HDFC Bank : 998.60 998.60(-0.45%) , Hind. Unilever : 2,321.10 2,321.10(0.29%) , ICICI Bank : 1,375.30 1,375.30(-1.01%) , Infosys : 1,597.50 1,597.50(-0.78%) , ITC : 403.50 403.50(0.34%) , Kotak Mah. Bank : 2,124.00 2,124.00(-0.36%) , Larsen & Toubro : 4,010.10 4,010.10(0.36%) , M & M : 3,625.00 3,625.00(-1.52%) , Maruti Suzuki : 16,151.35 16,151.35(-0.19%) , NTPC : 320.00 320.00(0.17%) , Power Grid Corpn : 264.55 264.55(-0.25%) , Reliance Industr : 1,533.15 1,533.15(-0.61%) , SBI : 962.05 962.05(0.62%) , Sun Pharma.Inds. : 1,790.00 1,790.00(-0.30%) , Tata Motors PVeh : 346.15 346.15(-0.56%) , Tata Steel : 161.95 161.95(-0.92%) , TCS : 3,204.90 3,204.90(-1.02%) , Tech Mahindra : 1,565.90 1,565.90(-1.62%) , Titan Company : 3,871.00 3,871.00(2.82%) , Trent : 4,085.20 4,085.20(-0.14%) , UltraTech Cem. : 11,480.00 11,480.00(-0.45%) ,

Nifty 50 : 25,880.45 -80.10(-0.31%) , Adani Enterp. : 2,249.00 32.80(1.48%) , Adani Ports : 1,492.60 12.10(0.82%) , Apollo Hospitals : 7,098.00 2.00(0.03%) , Asian Paints : 2,807.20 -121.10(-4.14%) , Axis Bank : 1,278.60 4.80(0.38%) , Bajaj Auto : 8,975.00 -51.00(-0.57%) , Bajaj Finance : 1,020.20 -6.20(-0.60%) , Bajaj Finserv : 2,073.20 14.00(0.68%) , Bharat Electron : 390.10 3.70(0.96%) , Bharti Airtel : 2,086.50 0.30(0.01%) , Cipla : 1,497.00 -0.60(-0.04%) , Coal India : 379.95 2.60(0.69%) , Dr Reddy's Labs : 1,256.10 -10.40(-0.82%) , Eicher Motors : 7,176.50 34.50(0.48%) , Eternal Ltd : 289.00 3.75(1.31%) , Grasim Inds : 2,770.60 26.40(0.96%) , HCL Technologies : 1,669.10 -19.50(-1.15%) , HDFC Bank : 999.00 -4.10(-0.41%) , HDFC Life Insur. : 758.55 -5.50(-0.72%) , Hind. Unilever : 2,320.50 6.50(0.28%) , Hindalco Inds. : 813.05 -6.40(-0.78%) , ICICI Bank : 1,377.20 -12.40(-0.89%) , Infosys : 1,596.50 -14.30(-0.89%) , Interglobe Aviat : 4,892.50 -31.00(-0.63%) , ITC : 403.90 1.60(0.40%) , Jio Financial : 295.10 -2.10(-0.71%) , JSW Steel : 1,111.80 -7.30(-0.65%) , Kotak Mah. Bank : 2,125.50 -6.10(-0.29%) , Larsen & Toubro : 4,009.90 13.20(0.33%) , M & M : 3,628.20 -53.50(-1.45%) , Maruti Suzuki : 16,154.00 -33.00(-0.20%) , Max Healthcare : 1,068.60 -10.80(-1.00%) , Nestle India : 1,219.40 4.60(0.38%) , NTPC : 320.10 0.60(0.19%) , O N G C : 239.51 0.99(0.42%) , Power Grid Corpn : 264.60 -0.60(-0.23%) , Reliance Industr : 1,534.30 -8.70(-0.56%) , SBI : 960.45 4.05(0.42%) , SBI Life Insuran : 2,000.00 -20.70(-1.02%) , Shriram Finance : 845.30 11.05(1.32%) , Sun Pharma.Inds. : 1,794.80 -1.40(-0.08%) , Tata Consumer : 1,144.90 -0.90(-0.08%) , Tata Motors PVeh : 346.80 -1.50(-0.43%) , Tata Steel : 161.64 -1.83(-1.12%) , TCS : 3,199.30 -37.20(-1.15%) , Tech Mahindra : 1,564.20 -27.60(-1.73%) , Titan Company : 3,851.60 84.60(2.25%) , Trent : 4,083.90 -6.60(-0.16%) , UltraTech Cem. : 11,499.00 -41.00(-0.36%) , Wipro : 258.08 -3.30(-1.26%) , Tuesday, December 09, 2025

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Hot Pursuit
04-Dec-2025     14:45
Lupin inks exclusive U.S. licensing deal with Valorum Biologics for biosimilar Armlupeg
Under the terms of the agreement, Valorum will handle the commercialization and distribution of Armlupeg in the United States, while Lupin will be responsible for manufacturing and supplying the product. Lupin will receive an upfront license fee along with royalty payments on net sales.

Armlupeg (pegfilgrastim-unne) is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients undergoing chemotherapy.

'We are pleased to collaborate with Valorum to expand access to affordable treatment options for patients undergoing chemotherapy. This partnership reflects our unwavering commitment to improving patient outcomes and aligns with our mission to make high-quality biosimilars more accessible. We look forward to strengthening our presence in the U.S. biosimilars market and building on our momentum as a global leader in developing and commercializing important biosimilar medicines,' said Spiro Gavaris, President ' U.S. Generics, Lupin.

Par S. Hyare, CEO of Valorum, said, 'We are excited to launch Armlupeg (pegfilgrastim-unne) in the U.S. Our team has a proven track record in specialty markets, and we expect to capture significant market share through our commercial expertise. Crucially, we also look forward to providing another option for healthcare providers and patients, increasing access to this important treatment in oncology supportive care.'

Valorum Biologics specializes in the U.S. commercialization of biosimilars, managing regulatory approval, product launch, and ongoing commercialization. The company focuses on optimizing patient access and delivering cost savings to the healthcare system.

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

Lupin reported a 73.33% surge in consolidated net profit to Rs 1,477.92 crore in Q2 FY26 as against Rs 852.63 crore posted in Q2 FY25. Revenue from operations jumped 24.27% year-on-year to Rs 6,831.43 crore in the quarter ended 30 September 2025.

The counter rose 0.47% to Rs 2,090.45 on the BSE.

Powered by Capital Market - Live News